Wegener’s granulomatosis is an autoimmune disease in which the immune system attacks small blood vessels, most commonly in the lungs, kidneys, and upper airways. The condition has been officially renamed granulomatosis with polyangiitis, or GPA, since 2010, after evidence surfaced that Friedrich Wegener, the physician who first described it comprehensively, had links to the Nazi regime in Germany. Despite the name change, many patients and even some clinicians still refer to it as “Wegener’s,” and search engines reflect that habit. The disease itself remains one of the more serious forms of small-vessel vasculitis, but modern treatment has turned what was once almost uniformly fatal into a manageable chronic condition for most people.
Why the Name Changed
Friedrich Wegener published the landmark clinical description of this disease in the 1930s, and for decades the medical community honored him by attaching his name to it. In 2006 and the years that followed, historical research revealed that Wegener had been a member of the Nazi party and was at least complicit in wartime activities that raised serious ethical concerns. By 2010, the American College of Rheumatology, the American Society of Nephrology, and the European League Against Rheumatism formally adopted the replacement name “granulomatosis with polyangiitis.”1PubMed. Undisclosed facts in Friedrich Wegener’s links with Nazism The abbreviation GPA is now the standard in medical literature, clinical guidelines, and patient education materials, though the older name lingers in conversation and in older reference texts.
What Happens Inside the Body
GPA belongs to a family of diseases called ANCA-associated vasculitides, or AAV. The “ANCA” part stands for anti-neutrophil cytoplasmic antibodies, which are autoantibodies that mistakenly target proteins on the surface of neutrophils, a type of white blood cell that normally fights infection. When these antibodies latch onto neutrophils, they trigger them to become hyperactive in the wrong place and at the wrong time. Inflammatory signals like TNF-alpha prime the neutrophils, and then ANCA binding pushes them into full activation, causing them to release toxic substances directly into the walls of small blood vessels.2PubMed Central. Mechanisms of vascular damage in ANCA vasculitis The result is tissue destruction at the blood-vessel level, which cascades into further immune-cell recruitment and more damage.
One detail that makes GPA especially destructive is the role of neutrophil extracellular traps, or NETs. When a neutrophil dies in this hyperactivated state, it can expel its own DNA in a web-like structure studded with antimicrobial proteins. Normally these NETs help trap bacteria, but in GPA they accumulate in tissues and are not broken down efficiently. A key enzyme called DNase I usually degrades NETs, but in patients with GPA the traps resist degradation and persist in inflamed tissue, fueling a cycle of ongoing damage and further autoantibody production.3PubMed. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis These NETs have been found deposited in the kidney’s filtering structures and in the walls of damaged blood vessels in GPA patients.4PubMed Central. Neutrophil Extracellular Traps Induce Tissue-Invasive Monocytes in Granulomatosis With Polyangiitis
The neutrophil damage is intense. Research has described it as the premature, explosive release by neutrophils of their full arsenal of cell-killing chemicals, weapons normally reserved for destroying bacteria inside infected tissue, now fired off inside blood vessel walls.5PubMed Central. Endothelium-neutrophil interactions in ANCA-associated diseases This is why GPA can cause such rapid, severe organ damage when it flares.
What GPA Does to the Body
GPA can technically affect almost any organ, but three areas bear the brunt: the upper airways, the lungs, and the kidneys. The disease tends to present differently depending on which organs are most involved, and it can look remarkably like other conditions, from cancer to severe infection.
The lungs are involved in over 90% of patients at some point during the course of the disease.6PubMed Central. Granulomatosis with polyangiitis presenting as high fever with diffuse alveolar hemorrhage and otitis media The most common lung finding on imaging is nodules or masses, often multiple and scattered across both lungs. These nodules typically range from 2 to 4 centimeters across, though some reach 10 centimeters. Roughly a quarter of the larger ones develop hollow centers with thick walls, mimicking the appearance of lung abscesses or metastatic cancer on a scan.7Respiratory Medicine Case Reports. Multiple pulmonary nodules in granulomatous polyangiitis: A case series This mimicry is one reason GPA is sometimes called “the great imitator” among vasculitides.
The most dangerous lung complication is diffuse alveolar hemorrhage, or bleeding into the air sacs. This occurs when the tiny capillaries in the lungs are destroyed by the vasculitis, and it can be life-threatening. Patients with diffuse alveolar hemorrhage have roughly six times the mortality rate of other GPA patients.8PubMed Central. Granulomatosis with polyangiitis presenting as high fever with diffuse alveolar hemorrhage and otitis media
In the upper airways, GPA frequently causes chronic sinusitis, nasal crusting, and nosebleeds. Over time, destruction of the nasal cartilage can lead to a saddle-nose deformity, where the bridge of the nose collapses inward. One study found that GPA patients with nasal septal perforations had dramatically higher odds of developing this deformity compared to non-GPA patients with similar perforations.9PubMed Central. Saddle Nose in Granulomatosis With Polyangiitis (GPA) vs. Non-GPA Patients With Septal Perforations Ear involvement, including hearing loss and middle-ear infections, is also common.
Kidney disease in GPA usually takes the form of rapidly progressive glomerulonephritis, where the kidney’s filtering units are attacked by crescentic inflammation. Without treatment, kidney function can decline over weeks rather than months. GPA predominantly affects the respiratory and renal systems, but it can also strike the eyes, skin, joints, and nervous system.10PubMed Central. Granulomatous Polyangiitis With Renal Involvement: A Case Report and Review of Literature
Diagnosis and Its Challenges
Diagnosing GPA typically involves a combination of clinical findings, blood tests, and tissue biopsy. The blood test most associated with GPA detects anti-neutrophil cytoplasmic antibodies, specifically those targeting a protein called proteinase 3, or PR3. When these antibodies produce a particular staining pattern in the lab, it is called c-ANCA (cytoplasmic ANCA), and a positive c-ANCA test strongly suggests GPA in the right clinical context.
The catch is that roughly 10 to 20% of patients with biopsy-proven GPA test negative for ANCA.11PubMed Central. ANCA-negative Granulomatosis with Polyangiitis: A Difficult Diagnosis This means a negative blood test does not rule out the disease, and diagnosis in ANCA-negative patients often requires a tissue biopsy showing the characteristic pattern of necrotizing granulomatous inflammation plus vasculitis. Biopsy is ideally taken from a site of active disease, such as the lung, kidney, or nasal tissue.
Classification systems have also evolved. The 2022 ACR/EULAR criteria provide a scoring system to distinguish GPA from the other ANCA-associated vasculitides, particularly microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome). When evaluated against a large Swedish cohort, these criteria agreed with older classification methods about 85% of the time for GPA, though a small percentage of patients remained unclassifiable or met criteria for more than one category.12Rheumatology. Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden In practice, the diagnosis still relies heavily on a clinician recognizing the overall pattern of disease rather than any single test result.
Treatment and the Shift Away From Steroids
GPA treatment follows two phases: induction, which aims to bring the disease under control rapidly, and maintenance, which keeps it there. Before effective treatments existed, GPA had a median survival of about five months. The introduction of cyclophosphamide combined with corticosteroids in the 1970s transformed the disease from a death sentence into something survivable, but both drugs carry serious long-term toxicity.
Over the past fifteen years, the biologic drug rituximab has become a central part of GPA management. Rituximab works by depleting B cells, the immune cells responsible for producing the harmful ANCA antibodies. In a weighted analysis comparing rituximab to cyclophosphamide for inducing remission in GPA, about 73% of rituximab-treated patients achieved the primary outcome versus roughly 40% on cyclophosphamide.13PubMed Central. Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis That said, an earlier randomized trial in patients with severe kidney-threatening ANCA vasculitis found that rituximab was not superior to cyclophosphamide, with sustained remission rates high in both groups and no significant difference in serious side effects.14PubMed. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis The clinical picture matters: rituximab may be especially favored for newly diagnosed or relapsing GPA, while cyclophosphamide retains a role in life-threatening presentations like severe kidney or lung hemorrhage.
Once remission is reached, expert guidance recommends prolonged maintenance therapy with low-dose rituximab infusions given roughly every six months to prevent relapse.15PubMed. How best to manage relapse and remission in ANCA-associated vasculitis This approach has shown benefits even for GPA-related eye disease: in a study of patients with GPA-associated scleritis, all treated eyes achieved remission during rituximab maintenance, with a median remission duration of 14 months.16PubMed. Rituximab Induction and Maintenance Treatment in Patients with Scleritis and Granulomatosis with Polyangiitis (Wegener’s)
A newer addition to the treatment landscape is avacopan, an oral drug that blocks the C5a receptor, a piece of the complement system that drives inflammation in GPA. Avacopan allows patients to taper off steroids faster and with less reliance on high-dose prednisone. In clinical use, it has helped patients reduce steroid exposure while maintaining disease control.17PubMed Central. Avacopan as a Steroid-Sparing Therapy in Relapsing Granulomatosis With Polyangiitis This matters because the long-term side effects of corticosteroids, including bone loss, diabetes, infections, and weight gain, are among the most debilitating aspects of living with GPA. In elderly patients, infection is the most common cause of death, and that risk correlates with how much oral steroid they have taken over time.18The Journal of Rheumatology. Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
Relapse and How Doctors Try to Predict It
Relapse is one of the defining frustrations of living with GPA. Even patients who achieve full remission face a substantial risk of the disease coming back, sometimes years later. Monitoring ANCA levels is one tool clinicians use, but rising ANCA titers alone are not reliably predictive of an impending flare in every patient.
Research has explored more refined approaches. One study tracked in vitro production of PR3-ANCA by immune cells and found that patients who relapsed had higher levels of this in vitro antibody production compared to those who stayed in remission. Patients whose in vitro PR3-ANCA exceeded a certain threshold at baseline had lower disease-free survival, while standard ANCA titer alone did not show the same predictive power.19ACR Meeting Abstracts. Predicting Relapse in Patients with Granulomatosis with Polyangiitis: The Potential Use of Monitoring in Vitro ANCA Production This kind of functional immune monitoring is still in the research phase, but it hints at a future where relapse prediction is more precise than simply checking antibody levels periodically.
In the meantime, clinical vigilance remains essential. Patients are typically seen regularly for blood work, urinalysis, and symptom assessment even when feeling well. New or worsening sinus symptoms, unexplained drops in kidney function, or new lung findings on imaging all warrant rapid evaluation.
Environmental Triggers and the Staphylococcus Connection
The causes of GPA are not fully understood, but epidemiologic research has identified several environmental and genetic risk factors that appear to contribute.20PubMed. Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement One of the more robust findings involves silica exposure. A systematic review and meta-analysis found that people with a history of silica exposure had roughly two and a half times the odds of developing ANCA-associated vasculitis, with similar risk estimates whether the vasculitis was GPA or MPA.21PubMed Central. The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis Silica dust is encountered in mining, construction, sandblasting, and certain manufacturing jobs, so occupational history is relevant when evaluating someone with suspected vasculitis.
An intriguing microbial connection has also emerged. Chronic nasal carriage of Staphylococcus aureus, a common bacterium that colonizes the nose in a sizable portion of the general population, has been linked to a higher relapse rate in GPA patients. A study found that patients who were chronic carriers of S. aureus were more prone to disease flares, suggesting the bacterium may play a role in triggering or sustaining the autoimmune process.22PubMed. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis This finding led to studies examining whether treating the nasal carriage with antibiotics could reduce relapses, and some centers still recommend nasal antibacterial ointment as part of maintenance care, though the evidence remains debated.
Fatigue, Mental Health, and Living With GPA
Patients who achieve remission from GPA often assume they should feel well, and many are caught off guard by the persistent fatigue, sleep problems, and mood changes that follow them. These issues are more than a footnote. In one study, over 76% of GPA patients reported fatigue, and about half said fatigue significantly limited their daily activities.23PubMed. Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener’s) Nearly 30% had abnormal daytime sleepiness scores. Fatigue correlated strongly with depression but not with standard measures of disease activity or damage, which is a source of frustration: patients feel terrible, but their lab work looks fine.
A more recent study found that about 45% of GPA patients reported clinically significant fatigue, and those who did had reduced ability to carry out daily living tasks. Fatigue scores correlated with markers of systemic inflammation and with disease duration, suggesting that the longer someone lives with GPA, the more likely fatigue becomes a persistent companion.24Advances in Rheumatology. Development of machine learning models for chronic fatigue prediction in granulomatosis with polyangiitis
Depression and anxiety are also common in GPA patients, and although the severity tends to be mild to moderate, the impact on quality of life is substantial. Patients with these psychosocial comorbidities report worse physical function, more pain, and poorer overall health assessments.25PubMed. Severity and determinants of psychosocial comorbidities in granulomatosis with polyangiitis and their impact on quality of life This is worth knowing because many GPA patients focus entirely on the vasculitis itself, and both patients and clinicians can underestimate the toll of chronic fatigue and low-grade mood disturbance on a person’s daily life. Screening for these issues and addressing them directly, rather than attributing every complaint to the underlying vasculitis, is an increasingly recognized part of good GPA care.
GPA in Children Versus Adults
GPA is rare in children, but it does occur, and the experience differs from adult disease in some important ways. A large U.S. claims database analysis comparing pediatric and working-age adult GPA patients found that children had more frequent hospitalizations and were two to three times more likely to develop treatment-related complications like low white blood cell counts and low antibody levels.26PubMed Central. Epidemiology and Outcomes of Granulomatosis with Polyangiitis (GPA) in Pediatric and Working-age Adults Populations in the United States Rates of severe infections were high in both groups, but children bore a disproportionate burden of immunosuppression side effects.
Pediatric GPA also poses diagnostic challenges because children are less likely to present with the classic triad of upper airway, lung, and kidney disease all at once. Initial symptoms may be mistaken for recurrent sinusitis or childhood asthma, delaying referral to a rheumatologist. At the other end of the age spectrum, elderly patients face their own challenges: they are more susceptible to treatment-related infections, and cumulative steroid exposure is a particular concern given their already elevated baseline risks for osteoporosis and diabetes.